Evidence map›Paper›PMID 31190739›Full record

SynthesisDrug design, development and therapy2019

Comparison of the efficacy and safety of remifentanil versus different pharmacological approaches on prevention of etomidate-induced myoclonus: a meta-analysis of randomized controlled trials.

Bingchen Lang, Lingli Zhang, Fengshan Li, Yunzhu Lin, Wensheng Zhang, Chunsong Yang

Registry-linked trialOpen access · goldAbstract readComparative StudyMeta-Analysis
In one paragraph

Synthesis in Drug design, development and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04921046 (Effect of Pretreatment of Lignocaine Versus Midazolam in the Prevention of Etomidate Induced Myoclonus), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04921046 phase4completednot on this map

Effect of Pretreatment of Lignocaine Versus Midazolam in the Prevention of Etomidate Induced Myoclonus

TypeinterventionalSponsorRawalpindi Medical CollegeRan2015 to 2015Enrolled224ConditionsMyoclonic JerkArmslignocaine, Midazolam 1 milligram Prefilled Syringe
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bingchen LangDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Lingli ZhangDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Fengshan LiDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Yunzhu LinDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Wensheng ZhangDepartment of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Chunsong YangDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Sichuan University · CNWest China Second University Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EtomidateHumansMyoclonusRandomized Controlled Trials as TopicRemifentanilEtomidateRemifentaniletomidatefentanylmeta-analysismidazolammyoclonusremifentanil

Identifiers

PMID31190739
PMCPMC6512956
OpenAlexW2944686458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.